Affirmation of collaboration between Public Health England and RIVM On Thursday 11 April 2019, RIVM welcomed a delegation from Public Health England (PHE). Chief Executive Duncan Selbie of PHE headed the delegation.
Salt, sugar and saturated fatty acid content in foods : RIVM Reformulation Monitor 2018 One of the aims of Dutch food policy is to make it easier for consumers to choose healthy foods.
Better insight into local residents’ exposure to pesticides Residues of pesticides were found in the air outside homes located near flower bulb fields, in the dust on their doormats and in the household dust.
Over 800 adverse effects of implants reported in 2018 The Dutch Reporting centre for adverse effects of medical implants (MEBI) received 162 reports of suspected adverse effects of implants. The notifications were linked to 181 implants.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.
iGEM meetup for teams and supervisors The best synbio projects, including iGEM teams, have one thing in common: cutting edge science in the light of carefully considered societal needs.
Research: HPV vaccine is safe RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.
New method for toxicological assessment of perfluoro mixtures Perfluoro (PFAS) is a group of substances that contains PFOS, PFOA and GenX. Perfluoro substances often occur as pollution in ground water and drinking water.
New Director-General Hans Brug starts at RIVM After the approval of his nomination on the proposal of Minister Ollongren of the Interior and Kingdom Relations on June 1 of this year, Professor J.